Clinical Trial Update: Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib [Phase 3]

View source ↗

Summary

Phase 3 booster study evaluating immunogenicity, reactogenicity, and safety of GSK's DTPw-HBV/Hib vaccine booster compared with the standard DTPw-HBV/Hib formul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• DTPw-HBV/Hib vaccine (Diphtheria and Tetanus Toxoids and Whole-Cell Pertussis vaccine, with Hepatitis B and Haemophilus influenzae type b)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Whole Cell Pertussis | Phase 3 | Status: COMPLETED